Knowledge fractional co2 laser machine How can clinicians precisely control crater depth during continuous-wave CO2 laser vaporization treatments to avoid overtreatment or recurrence? Calibrated energy and stepwise verification are key.
Author avatar

Tech Team · Belislaser

Updated 3 months ago

How can clinicians precisely control crater depth during continuous-wave CO2 laser vaporization treatments to avoid overtreatment or recurrence? Calibrated energy and stepwise verification are key.


Clinicians can control crater depth by standardizing laser power, spot size, and exposure time, then confirming the result incrementally rather than relying on visual judgment alone. For a fixed spot and tissue type, delivered energy—and therefore fluence—can be calculated from power and time: energy (J) = power (W) × time (s), while fluence (J/cm²) = energy ÷ spot area. A cited example is 10 W applied through a 1 mm spot for 1 second, which is associated with an approximately 2.5 mm penetration depth under the specified conditions; however, this should be treated as a calibration reference, not a universal guarantee.

The safest approach is a calibrated, stepwise protocol: calculate energy density, use validated device-specific depth data, apply treatment in controlled increments, and reassess the crater after each pass. This reduces both undertreatment-related recurrence and overtreatment-related scarring.

Why visual inspection alone is unreliable

Surface appearance does not equal crater depth

During continuous-wave CO₂ vaporization, the visible tissue response reflects more than pure vaporization. Thermal coagulation, desiccation, bleeding, tissue composition, and smoke can obscure the true depth.

A crater that appears adequately treated may still contain residual lesion. Conversely, extending treatment until all visible abnormality disappears can unnecessarily increase depth and thermal injury.

Both errors have clinical consequences

Undertreatment can leave residual pathology and contribute to recurrence. Overtreatment can increase scarring, delayed healing, prolonged erythema, edema, pigmentary change, and injury to adjacent healthy tissue.

The objective is therefore not simply to maximize ablation, but to reach the required target layer with the smallest effective thermal burden.

How power, time, and spot size determine delivered energy

Calculate total energy first

For continuous-wave operation:

[ E = P \times t ]

where E is energy in joules, P is power in watts, and t is exposure time in seconds.

For example, 10 W applied for 1 second delivers 10 J. Increasing the exposure to 2 seconds at the same power doubles the delivered energy.

Convert energy to fluence

Fluence describes energy delivered per unit area:

[ F = \frac{P \times t}{A} ]

where F is fluence in J/cm² and A is the treated spot area.

A smaller spot concentrates the same energy into a smaller area, increasing fluence and generally increasing the potential for deeper or more intense tissue effects. Spot diameter must therefore be recorded consistently, and the area should be calculated from the actual beam geometry rather than assumed.

Recognize that exposure pattern matters

A stationary beam, a moving beam, and repeated overlapping passes do not produce identical craters, even when their total calculated energy appears similar. Dwell time, scan speed, overlap, beam mode, tissue hydration, and heat conduction all affect the final depth and surrounding thermal damage.

A practical method for precise depth control

Establish a device- and tissue-specific calibration

Use manufacturer data, published evidence, and institutional experience to create a treatment matrix linking:

  • Power
  • Spot diameter and beam mode
  • Exposure time or scan speed
  • Number of passes
  • Degree of overlap
  • Expected ablation depth
  • Expected surrounding coagulation

The cited 10 W, 1 mm spot, 1-second exposure, approximately 2,500 µm example can serve as a reference point only when the same device configuration, tissue, and delivery conditions apply.

Use test spots when clinically appropriate

A test exposure on representative tissue can help confirm the device’s actual effect before treating the full lesion. The result should be assessed using the clinician’s chosen depth-verification method rather than by color change alone.

A calibration performed on one tissue type should not automatically be transferred to another. Thickness, hydration, fibrosis, vascularity, and anatomic location can materially change ablation behavior.

Treat in controlled increments

Instead of attempting the full planned crater in one prolonged exposure, use shorter, measured applications or passes with reassessment between them. This allows the operator to stop when the target depth has been reached and reduces the risk of an irreversible overshoot.

If multiple passes are used, overlap should be deliberately controlled and documented. Unplanned overlap can create localized hot spots and deeper-than-intended regions.

Document the variables

The operative record should include the parameters that determine dose:

  • Laser mode
  • Power
  • Spot size
  • Exposure time or movement speed
  • Number of passes
  • Overlap pattern
  • Estimated or verified depth
  • Tissue response and endpoint

This makes the treatment reproducible and helps refine future settings for the same lesion type and location.

How to balance recurrence prevention with tissue preservation

Define the required target depth

The intended depth should be based on the lesion’s anatomy and therapeutic endpoint, not on a generic “deeper is better” principle. The operator should identify the tissue layer requiring removal or remodeling and set the minimum effective ablation depth accordingly.

For scar remodeling, fractional CO₂ treatment is often discussed in the range of approximately 1.0–1.2 mm, with the goal of reaching the relevant dermal layer while limiting collateral thermal injury. Those values should not be assumed to apply directly to continuous-wave crater vaporization, because fractional and fully ablative delivery create different treatment geometries and thermal profiles.

Separate ablation depth from thermal injury

The visible crater represents tissue removal, but the surrounding coagulation zone can also influence healing and complications. A setting that reaches the desired depth may still be excessive if it produces unnecessary lateral or peripheral heating.

Depth planning should therefore consider both vertical ablation and ** 주변 thermal spread**—particularly in cosmetically sensitive or anatomically constrained areas.

Use clinical endpoints as confirmation, not as the sole control

Visual and tactile endpoints remain useful, but they should confirm a preplanned dose rather than replace it. A consistent endpoint may include the expected tissue texture or appearance, absence of untreated lesion, and preservation of the intended anatomic boundaries.

Where available and appropriate, objective depth assessment or histologic confirmation can improve calibration, especially when treatment consequences are significant.

Understanding the Trade-offs

A numerical setting is not a universal depth prescription

The relationship between fluence and depth is not perfectly deterministic across all patients and tissues. The primary reference’s 2.5 mm example is condition-specific; it should not be presented as a guaranteed result for every 10 W, 1 mm, 1-second exposure.

Device calibration, pulse delivery characteristics, tissue composition, and beam profile can all change the outcome.

Longer exposure can increase collateral damage

With continuous-wave delivery, heat has time to conduct beyond the vaporized zone. Increasing dwell time may therefore deepen the crater while also widening the thermal injury zone.

When the treatment goal permits it, controlled incremental applications may provide better control than one prolonged exposure, but the exact protocol must be validated for the specific laser and indication.

Fractional data cannot be directly substituted

Fractional CO₂ studies commonly describe controlled depths and reduced thermal burden because only a fraction of the surface is treated. Those parameters cannot be transferred directly to a continuous-wave, fully ablative crater.

Using fractional settings or outcomes as though they were equivalent to continuous-wave vaporization can produce either inadequate treatment or excessive injury.

Avoid treating “complete visual clearance” as the endpoint

Aggressively vaporizing until every visible abnormality has disappeared can lead to unnecessary depth, especially when the lesion boundary is obscured by smoke, bleeding, or thermal change. The endpoint should be tied to anatomy and calibrated dose, with incremental reassessment.

How to Apply This to Your Project

Use the following principles when developing or reviewing a clinical protocol:

  • If your primary focus is precise crater depth: Standardize power, spot size, exposure time, beam geometry, and pass overlap, then calculate energy and fluence before treatment.
  • If your primary focus is preventing recurrence: Define the lesion-specific target layer and verify adequate treatment incrementally rather than relying only on surface appearance.
  • If your primary focus is minimizing scarring and pigmentary complications: Use the lowest validated dose that reaches the therapeutic target, limit unnecessary overlap and dwell time, and account for surrounding thermal injury.
  • If your primary focus is reproducibility: Build a device- and tissue-specific calibration chart and document every treatment parameter and observed endpoint.
  • If your primary focus is scar remodeling: Do not transfer fractional CO₂ depth ranges directly to continuous-wave vaporization; validate the settings for the actual delivery mode and clinical indication.

Precise control comes from calibrated energy delivery, incremental verification, and respect for the variability of living tissue—not from visual inspection alone.

Summary Table:

Parameter Role in Depth Control Practical Guidance
Power (W) Determines energy delivery rate Set according to device calibration and tissue type
Spot Size (mm) Affects fluence and depth Measure actual beam diameter; smaller spots increase fluence
Exposure Time (s) Determines total energy Use short pulses or controlled passes for precision
Fluence (J/cm²) Energy density per area Calculate using P×t/A before treatment
Number of Passes Cumulative effect Treat incrementally with reassessment
Overlap Influences localized hot spots Document and control to avoid overtreatment
Tissue Type Modifies ablation depth Calibrate for each tissue condition
Beam Mode Affects thermal profile Use validated settings for specific device and mode

Ready to enhance your clinical precision? BELIS offers advanced CO2 fractional and continuous-wave laser systems designed for professional aesthetic practices. Our devices provide precise energy control and validated parameters to help you achieve optimal outcomes with minimal risk. Contact our experts today to schedule a demo and learn how BELIS can elevate your treatment results. Contact us now and discover the difference.

Related Products

People Also Ask

Related Products

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin rejuvenation, scar removal, and gynecological treatments. Dual-mode precision with customizable settings. Learn more now!

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin resurfacing, scar removal & anti-aging. 40W/60W power, adjustable modes & minimal downtime. FDA-approved for safe treatments.

Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine

Cryolipolysis Fat Freezing Cavitation Lipo Laser Machine

Non-invasive Cryolipolysis-Cavitation-Lipo Laser machine for fat reduction, body contouring, and skin tightening. Ideal for clinics and spas.

Cryolipolysis Fat Freezing Machine and Ultrasonic Cavitation Device

Cryolipolysis Fat Freezing Machine and Ultrasonic Cavitation Device

Advanced body contouring system with cryolipolysis, RF, and laser for fat reduction and skin tightening. Non-invasive, FDA-cleared, visible results.


Leave Your Message